Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer-a finding from Texas lung cancer genome-wide association study

Carcinogenesis

Volumn 32, Issue 4, 2011, Pages 507-515

  Wei, Sheng ^a   Niu, Jiangong ^a   Zhao, Hui ^a   Liu, Zhensheng ^a   Wang, Li E ^a   Han, Younghun ^a   Chen, Wei V ^a   Amos, Christopher I ^a   Rafnar, Thorunn ^b   Sulem, Patrick ^b   Stefansson, Kari ^b   Landi, Maria T ^c   Caporaso, Neil E ^c   Albanes, Demetrius ^c   Thun, Michael J ^d   McKay, James D ^e   Brennan, Paul ^e   Wang, Yufei ^f   Houlston, Richard S ^f   Spitz, Margaret R ^a   Wei, Qingyi ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b DECODE GENETICS   (Iceland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d AMERICAN CANCER SOCIETY   (United States)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 LIGAND; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER RISK; CELL STRAIN HCT116; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; UNITED STATES;

ADULT; AGED; ANTIGENS, CD30; APOPTOSIS; CD30 LIGAND; CELL LINE, TUMOR; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; TEXAS;

EID: 79953697107     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr014     Document Type: Article

References (43)

1. Spitz,M.R. et al. (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol. Biomarkers Prev., 12, 689-698.
2. Neumann,A.S. et al. (2005) Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog., 42, 65-92.
3. Wang,L. et al. (2006) Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiol. Biomarkers Prev., 15, 2364-2369.
4. Wang,L. et al. (2007) Polymorphisms of cytosolic serine hydroxymethyl-transferase and risk of lung cancer: a case-control analysis. Lung Cancer, 57, 143-151.
5. Easton,D.F. et al. (2008) Genome-wide association studies in cancer. Hum. Mol. Genet., 17, R109-R115.
6. Amos,C.I. et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet., 40, 616--622.
7. Wang,Y. et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet., 40, 1407-1409.
8. McKay,J.D. (2008) Lung cancer susceptibility locus at 5p15.33. Nat. Genet., 40, 1404-1406.
9. Hung,R.J. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452, 633-637.
10. Manolio,T.A. (2009) Finding the missing heritability of complex diseases. Nature, 461, 747-753.
11. Eichler,E.E. et al. (2010) Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet., 11, 446-450.
12. Donnelly,P. (2008) Progress and challenges in genome-wide association studies in humans. Nature, 456, 728-731.
13. Hong,M.G. et al. (2009) Strategies and issues in the detection of pathway enrichment in genome-wide association studies. Hum. Genet., 126, 289-301.
14. Ioannidis,J.P. et al. (2009) Validating, augmenting and refining genomewide association signals. Nat. Rev. Genet., 10, 318-329.
15. Elmore,S. (2007) Apoptosis: a review of programmed cell death. Toxicol. Pathol., 35, 495-516.
16. Shivapurkar,N. et al. (2003) Apoptosis and lung cancer: a review. J. Cell Biochem, 88, 885-898.
17. Catassi,A. et al. (2008) Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat. Res., 659, 221-231.
18. Cotter,T.G. (2009) Apoptosis and cancer: the genesis of a research field. Nat. Rev. Cancer, 9, 501-507.
19. Wang,L.E. et al. (2003) Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer, 42, 1-8.
20. Ter-Minassian,M. et al. (2008) Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis, 29, 2147-2152.
21. Zhang,X. et al. (2005) Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J. Med. Genet., 42, 479-484.
22. Zeiss,C.J. (2003) The apoptosis-necrosis continuum: insights from genetically altered mice. Vet. Pathol., 40, 481-495.
23. Xu,Z. et al. (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res., 37, W600-W605.
24. Heinemeyer,T. et al. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res., 26, 362-367.
25. Andrews,N.C. et al. (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res., 19, 2499.
26. Purcell,S. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
27. Barrett,J.C. et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
28. Thorgeirsson,T.E. et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452, 638-642.
29. Landi,M.T. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet., 85, 679-691.
30. Diaconu,N.C. et al. (2007) Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma. Cancer Immunol. Immunother., 56, 1407-1415.
31. Duckett,C.S. et al. (1997) CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev., 11, 2810-2821.
32. Oflazoglu,E. et al. (2009) Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases. Adv. Exp. Med. Biol., 647, 174-185.
33. Chiarle,R. et al. (1999) CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. J. Immunol., 163, 194-205.
34. Horie,R. et al. (2002) Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells. Oncogene, 21, 2493-2503.
35. Kennedy,M.K. et al. (2006) Deciphering CD30 ligand biology and its role in humoral immunity. Immunology, 118, 143-152.
36. Florido,M. et al. (2009) Delayed recruitment of lymphocytes into the lungs of CD30-deficient mice during aerogenic Mycobacterium avium infections. Immunobiology, 214, 643-652.
37. Nam,S.Y. et al. (2008) CD30 supports lung inflammation. Int. Immunol., 20, 177-184.
38. Croager,E.J. et al. (1997) Characterisation of the human CD30 ligand gene structure. Biochim. Biophys. Acta, 1353, 231-235.
39. Durie,B.G.M. et al. (2009) Genetic polymorphisms of EPHX1, Gsk3[beta], TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma. Leukemia, 23, 1913-1919.
40. Liu,Y.J. et al. (2008) Is replication the gold standard for validating genomewide association findings? PLoS One, 3, e4037.
41. Cazier,J.B. et al. (2010) General lessons from large-scale studies to identify human cancer predisposition genes. J. Pathol., 220, 255-262.
42. Scelo,G. et al. (2004) Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (Europe). Cancer Causes Control, 15, 445-452.
43. Khoury,M.J. et al. (2009) Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am. J. Epidemiol., 170, 269-279.